Finance

Beta
Lists
NNVC:NYSEAMERICAN
NanoViricides, Inc
$1.38
-8.00%
(-0.12) 1D
$1.44
+4.35% (+0.060)
After hours
Closed: Jun 5, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NNVC...
Open
$1.50
High
$1.54
Low
$1.36
Mkt. cap
31.44M
Avg. vol.
1.54M
Volume
682.90K
52-wk high
$2.23
52-wk low
$0.85
EPS
-$0.44
Beta
1.66
Shares outstanding
22.78M
No. of employees
7
Open
$1.50
High
$1.54
Low
$1.36
Mkt. cap
31.44M
Avg. vol.
1.54M
Volume
682.90K
52-wk high
$2.23
52-wk low
$0.85
EPS
-$0.44
Beta
1.66
Shares outstanding
22.78M
No. of employees
7
Analyst outlook
Analyst Ratings
Based on 1 analyst giving stock ratings to NNVC in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12 month forecast
Based on 1 Wall Street analyst offering 12 month price targets for NNVC in the last 3 months.
Highest
Current $1.38
$6.00 (+334.78%)
Average
$6.00 (+334.78%)
Lowest
$6.00 (+334.78%)
News stories
From sources across the web
About NanoViricides, Inc
CEO-
Employees7
Founded2005
HeadquartersShelton, Connecticut, United States
SectorBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1.18M
993.07K
1.12M
1.29M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
938.20K
803.62K
1.11M
744.28K
Operating expense
2.12M
1.80M
2.23M
2.03M
Total operating expenses
2.12M
1.80M
2.23M
2.03M
Operating income
-2.12M
-1.80M
-2.23M
-2.03M
Other non operating income
-
-
-
-
EBT including unusual items
-2.10M
-1.79M
-2.22M
-1.99M
EBT excluding unusual items
-2.10M
-1.79M
-2.22M
-1.99M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-2.10M
-1.79M
-2.22M
-1.99M
Net profit margin
-
-
-
-
Earnings per share
-
-
-0.11
-0.09
Interest and investment income
19.72K
11.63K
12.46K
40.88K
Interest expense
-
-
-
-
Net interest expenses
19.72K
11.63K
12.46K
40.88K
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.95M
-1.66M
-2.10M
-1.90M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more